Myocardial Infarction in the Elderly
Recruiting
- Conditions
- Myocardial Infarction (MI)
- Registration Number
- NCT06860646
- Lead Sponsor
- Ryazan State Medical University
- Brief Summary
An observational registry study of patients aged 75 years and older with an established diagnosis of myocardial infarction, initiated in 2020, with an assessment of clinical, instrumental, demographic and prognostic data. Statistical analysis was performed using the StatTech v. 4.5.0 program (developer - StatTech LLC, Russia). Differences were considered statistically significant at p \<0.05.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
- age 75 years and older, presence of an established diagnosis of myocardial infarction at the time of hospitalization.
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method all-cause death, myocardial infarction, stroke, unplanned percutaneous coronary 10 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are implicated in myocardial infarction pathogenesis among patients aged 75+?
How do antiplatelet therapies compare in efficacy and safety for elderly vs. younger MI patients?
Which biomarkers predict adverse outcomes in NCT06860646 elderly myocardial infarction cohort?
What are the most common adverse events in elderly MI patients post-hospitalization and management strategies?
How effective are SGLT2 inhibitors in reducing cardiovascular mortality in elderly MI patients compared to standard care?
Trial Locations
- Locations (1)
State Budgetary Institution of the Ryazan Region "Regional Clinical Cardiology Dispensary"
🇷🇺Ryazan, Russian Federation